The overall uptake of RSV vaccine is low during its first season in those aged 60 years or older in the United States. The ...

A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...

The health and human services secretary, Robert F. Kennedy Jr., is known for his criticism of advisory panels, most recently ...

After the monoclonal antibody nirsevimab (Beyfortus) became available to prevent respiratory syncytial virus (RSV) in infants ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

The U.S. Department of Health and Human Services and the National Institutes of Health announced a new initiative called ...

The U.S. Department of Health and Human Services and the National Institutes of Health made an announcement of the latest ...

We recently published a list of 11 Best Breakout Stocks to Buy According to Analysts. In this article, we are going to take a ...